Current State and Future Directions of Technology-Based Ecological Momentary Assessment and Intervention for Major Depressive Disorder: A Systematic Review

Desirée Colombo, Javier Fernández‐Álvarez, Andrea Patanè, Michelle Semonella, Marta Kwiatkowska, Azucena García‐Palacios, Pietro Cipresso, Giuseppe Riva, Cristina BotellaJournal of Clinical Medicine 2019 · DOI

TL;DR

This systematic review explores the current landscape of technology-based Ecological Momentary Assessment (EMA) and Intervention (EMI) for Major Depressive Disorder (MDD). It highlights the growing potential of smartphones and wearables to revolutionize how we understand, assess, and treat depression by collecting real-time data in naturalistic settings, while also identifying key challenges and future directions for this field.

What Problem Does This Paper Address?

Traditional methods for assessing and treating Major Depressive Disorder (MDD) often rely on retrospective self-reports and face-to-face therapy. However, these methods have limitations: retrospective reports are prone to recall bias and may not accurately capture the fluctuating nature of depressive symptoms. Face-to-face therapy, while valuable, can be limited by accessibility and the challenge of translating insights into daily life. The paper addresses the gap in understanding how emerging technologies, specifically smartphones and wearable biosensors, can overcome these limitations by enabling continuous, real-world data collection (EMA) and delivering timely support (EMI) for individuals with MDD.

Methods

The authors conducted a systematic review following PRISMA guidelines. They searched two major databases (PubMed and Web of Science) using a comprehensive string of keywords related to EMA, EMI, and depression. They included studies focusing on adults with a primary diagnosis of MDD, utilizing technology-based approaches and excluding non-English papers, reviews, and certain manuscript types. Data extraction focused on technical aspects (sampling, duration, prompts), clinical aspects (application, adherence, outcomes), and technological aspects (devices used). For EMI studies, a quality assessment using the Downs and Black quality index was performed.

Datasets

Not discussed in the paper. The paper focuses on a systematic review of existing literature rather than introducing new datasets or benchmarks.

Key Insights and Ideas

  • The "Ecological" Advantage: EMA and EMI leverage the "ecological" aspect by collecting data in real-world settings, providing a more authentic picture of a patient's experience than lab-based assessments.
  • Momentary Precision: The "momentary" aspect allows for capturing the immediate affective and behavioral dynamics of depression, which are often missed in traditional assessments.
  • Smartphone & Wearable Revolution: The proliferation of smartphones and wearable biosensors offers unprecedented opportunities for continuous, unobtrusive data collection and personalized interventions.
  • Bridging the Gap: Technology-based EMA and EMI hold significant promise for bridging the gap between clinical research and real-world practice, making mental health support more accessible and integrated into daily life.
  • Beyond Self-Reports: The integration of biosensor data (e.g., heart rate, activity levels) with self-reports offers a multimodal approach to understanding depression, moving beyond subjective reporting.

Key Results

The review included 33 articles: 26 focusing on EMA and 7 on EMI for MDD.

  • EMA Dominance: The majority of studies (26) focused on EMA, primarily using smartphones or PDAs for daily self-reports.
  • Sensor Integration is Growing but Limited: While the potential of sensors and biosensors is recognized, only a minority of EMA studies (7 out of 32) integrated physiological measures. Common sensor data included actigraphy for sleep/activity and physiological measures like heart rate.
  • High Adherence Rates: Most studies reported encouraging compliance rates, often exceeding 70%, with some reaching over 85%. Dropout reasons were varied, including technical issues and symptom worsening.
  • Promising EMI Efficacy: The reviewed EMI studies showed promising results, including significant reductions in depressive symptoms and improved patient empowerment.
  • Technological Diversity: A range of devices were used, from PDAs and smartphones to specialized garments with integrated biosensors.
  • Key Application Areas: EMA has been applied to understand recall bias, monitor symptoms, analyze cortisol dysregulation, sleep patterns, physical activity, rumination, and affect/emotional reactivity in MDD.

Limitations and Future Work

  • Clinical Practice Gap: Despite promising research, the adoption of technology-based EMA and EMI in clinical practice remains limited.
  • Standardization Needed: There's a lack of standardized and validated item sets for EMA protocols, impacting context validity.
  • Compliance Challenges: While generally good, compliance can still be an issue, especially with prolonged or technically problematic interventions. Future work should focus on improving user motivation, engagement, and reducing dropout.
  • Technical Hurdles: Some studies reported technical difficulties with devices or connectivity, impacting data collection and user experience.
  • Machine Learning Potential: The authors emphasize the significant potential of integrating machine learning with sensor data for more sophisticated affective modeling and personalized interventions.
  • Need for More RCTs: While promising, more high-quality randomized controlled trials are needed to definitively establish the efficacy of EMI interventions.
  • Tailoring and Engagement: Future interventions should be more tailored to individual needs and incorporate features like gamification to enhance adherence.
  • Ecological Validity vs. Control: While EMA offers high ecological validity, it presents challenges in experimental control due to the naturalistic setting. Finding a balance between research needs and clinical utility is crucial.

Summary updated

Abstract

Ecological momentary assessment (EMA) and ecological momentary intervention (EMI) are alternative approaches to retrospective self-reports and face-to-face treatments, and they make it possible to repeatedly assess patients in naturalistic settings and extend psychological support into real life. The increase in smartphone applications and the availability of low-cost wearable biosensors have further improved the potential of EMA and EMI, which, however, have not yet been applied in clinical practice. Here, we conducted a systematic review, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, to explore the state of the art of technology-based EMA and EMI for major depressive disorder (MDD). A total of 33 articles were included (EMA = 26; EMI = 7). First, we provide a detailed analysis of the included studies from technical (sampling methods, duration, prompts), clinical (fields of application, adherence rates, dropouts, intervention effectiveness), and technological (adopted devices) perspectives. Then, we identify the advantages of using information and communications technologies (ICTs) to extend the potential of these approaches to the understanding, assessment, and intervention in depression. Furthermore, we point out the relevant issues that still need to be addressed within this field, and we discuss how EMA and EMI could benefit from the use of sensors and biosensors, along with recent advances in machine learning for affective modelling.
BibTeX
@article{colombo2019current,
  author = {Desirée Colombo and Javier Fernández‐Álvarez and Andrea Patanè and Michelle Semonella and Marta Kwiatkowska and Azucena García‐Palacios and Pietro Cipresso and Giuseppe Riva and Cristina Botella},
  title = {{Current State and Future Directions of Technology-Based Ecological Momentary Assessment and Intervention for Major Depressive Disorder: A Systematic Review}},
  journal = {Journal of Clinical Medicine},
  year = {2019},
  doi = {10.3390/jcm8040465},
}
Figure